Quarterly report pursuant to sections 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v2.4.0.8
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 96 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Income Statement [Abstract]      
REVENUES       $ 92,903
OPERATING EXPENSES:      
Stock based compensation 9,104,625 3,615 10,704,092
Selling, general, and administrative expenses 1,797,969 266,063 15,229,075
Research and development 250,234 170,319 15,792,520
Depreciation and amortization 7,505 8,242 1,430,731
Total operating expenses 11,160,333 448,239 43,156,418
Loss from operations (11,160,333) (448,239) (43,063,515)
OTHER INCOME (EXPENSES):      
Interest income 1,154    1,154
Net loss on sale of assets       (37,878)
Research grant income       1,179,646
Gain on debt extinguishment       786,945
Federal and state tax credits       1,506,596
Dividend income       55,206
Other expenses, net (8,708) (494) (184,319)
Interest expense (117,042) (145,559) (4,426,421)
Total other expenses (124,596) (146,053) (1,119,071)
Loss before the provision for income taxes (11,284,929) (594,292) (44,182,586)
PROVISION FOR INCOME TAXES, net         
NET LOSS $ (11,284,929) $ (594,292) $ (44,182,586)
NET LOSS PER SHARE      
Basic $ (0.22) $ (0.02)  
Diluted $ (0.22) $ (0.02)  
SHARES USED IN CALCULATION OF NET INCOME PER SHARE      
Basic 50,346,094 33,229,093  
Diluted 50,346,094 33,229,093